The Effect of Bilateral Intravitreal Ranibizumab Administration on Pain in Diabetic Retinopathy
Öz
Anahtar Kelimeler
Kaynakça
- Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
- Küçükerdönmez C, Gelisken F, Yoeruek E, et al. Switching intravitreal anti-VEGF treatment in neovascular age-related macular degeneration. Eur J Ophthalmol. 2015;25:51-6.
- Raj PP Ağri Taksonomisi. In: Erdine S, ed., Ağrı. Nobel Tıp Kitabevleri, İstanbul. 2000;12-9.
- Black JM, Matasarrin-Jacobs E. Medical-surgical nursing, 4th edition, WB Saunders Co., London 1993;313-58.
- Boccard E, Garbior JL. Pain and its expression in six European Countries: a survey. Pain Clin. 1996;9:77-88.
- Aiello LP, Brucker AJ, Chang S et al. Evolving guidelines for intravitreous injections. Retina. 2004;24:S3-19.
- Cintra LP, Lucena LR, Da Silva JA et al. Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging. 2009;40:13-8.
- Ertan E, Duman R, Duman R. Comparison of pain during intravitreal dexamethasone, ranibizumab and aflibercept injection. Clin Exp Optom. 2020;103:630-3.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Göz Hastalıkları
Bölüm
Klinik Araştırma
Yazarlar
Mehmet Coşkun
*
0000-0001-7315-2994
Türkiye
Yayımlanma Tarihi
31 Ocak 2024
Gönderilme Tarihi
15 Aralık 2023
Kabul Tarihi
28 Ocak 2024
Yayımlandığı Sayı
Yıl 2024 Cilt: 6 Sayı: 1